Abstract ISI
 (2018)

Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies

Armand, P; Rodig, SJ; Melnichenko, V; Thieblemont, C; Bouabdallah, K; Tumyan, G; Ozcan, M; Portino, S; Fogliatto, L; Caballero, D; Walewski, J; Gulbas, Z; Ribrag, V; Christian, BA; Perini, GF; et. al.